Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.41 |
| ▸ | ADH1B | P00325 | 2/20 | 0.35 |
| ▸ | ADH1C | P00326 | 2/20 | 0.35 |
| ▸ | ADH1A | P07327 | 2/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4978224 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL294142 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL293702 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL536858 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL2523320 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL5654128 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL756048 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL15327039 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL21619221 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA | |
| SCHEMBL9254348 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1HIF1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 746 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680020-A1 | COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES | FMC Agricultural Solutions A/S (DK) | 2026-01-21 | — | — | EP | claimed |
| WO-2024189207-A1 | COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES | FMC Agricultural Solutions A/S (DK) | 2024-09-19 | — | — | WO | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-114870847-B | Preparation method of copper-zinc-aluminum gas-phase hydrogenation catalyst, prepared catalyst and application | 广东石油化工学院 | 2023-04-18 | — | — | CN | claimed |
| CN-114870847-A | Preparation method of copper-zinc-aluminum gas phase hydrogenation catalyst, prepared catalyst and application | 广东石油化工学院 | 2022-08-09 | — | — | CN | claimed |
| CN-113582821-A | Preparation method of 8-methyl decanal | 泛亚（武汉）食品科技有限公司 | 2021-11-02 | — | — | CN | claimed |
| CN-106456588-B | Methods for the microbial production of capsaicinoids using capsaicin synthase | 科纳根公司 | 2021-04-30 | — | — | CN | claimed |
| US-10711040-B2 | Low substituted polymyxins and compositions thereof | XELLIA PHARMACEUTICALS APS (DK) | 2020-07-14 | — | — | US | claimed |
| US-10640536-B2 | Polymyxins, compositions, methods of making and methods of use | XELLIA PHARMACEUTICALS APS (DK) | 2020-05-05 | — | — | US | claimed |
| EP-3166960-B1 | LOW SUBSTITUTED POLYMYXINS AND COMPOSITIONS THEREOF | XELLIA PHARMACEUTICALS APS (DK) | 2019-08-07 | — | — | EP | claimed |
| US-5039789-A | Antibacterial agents | ELI LILLY AND COMPANY (US) | 1991-08-13 | — | — | US | claimed |
| US-5028590-A | Animal Growth Promoters | ELI LILLY AND COMPANY (US) | 1991-07-02 | — | — | US | claimed |
| US-4977083-A | Feeding alkanoic or alkenoic acids, esters, salts or alcohols to cultures of Streptomyces fradiae | ELI LILLY AND COMPANY (US) | 1990-12-11 | — | — | US | claimed |
| WO-1990011300-A1 | NEW SUBSTITUTED ALKYLAMIDE DERIVATIVES OF TEICOPLANIN | GRUPPO LEPETIT S.P.A. (IT) | 1990-10-04 | — | — | WO | claimed |
| CN-1043941-A | 34-takes off the C63 amide derivatives of (N-acetyl glucosamine amido)-34-deoxidation-teicoplanins | LEPETIT SPA (IT) | 1990-07-18 | — | — | CN | claimed |
| EP-0376041-A2 | C63-Amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanins | GRUPPO LEPETIT S.p.A. (IT) | 1990-07-04 | — | — | EP | claimed |
| EP-0340245-A1 | SUBSTITUTED ALKYLAMIDES OF TEICOPLANIN COMPOUNDS. | LEPETIT SPA (IT) | 1989-11-08 | — | — | EP | claimed |
| EP-0337731-A2 | Peptide antibiotics | ELI LILLY AND COMPANY (US) | 1989-10-18 | — | — | EP | claimed |
| CN-88101000-A | The alkylamide of the replacement of teicoplanin compounds | — | 1988-09-14 | — | — | CN | claimed |
| WO-1988006600-A1 | SUBSTITUTED ALKYLAMIDES OF TEICOPLANIN COMPOUNDS | GRUPPO LEPETIT S.P.A. (IT) | 1988-09-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10640536-B2 | Polymyxins, compositions, methods of making and methods of use | C5, HRH3, SGMS1 | TSHR 2796/4885FAAH 1266/4885TRPV1 2910/4885 |
| US-10711040-B2 | Low substituted polymyxins and compositions thereof | TLR3, TLR4, TLR5 | TSHR 4714/4885FAAH 4427/4885TRPV1 1780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.